Evoke Wealth, LLC Nektar Therapeutics Transaction History

Evoke Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$3.17 - $6.17 $18,934 - $36,853	-5,973 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$4.16 - $13.72 $8,432 - $27,810	-2,027 Reduced 25.34%	5,973 $32,000
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $104,560 - $150,720	8,000 New	8,000 $143,000
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $2,255 - $2,721	-143 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$16.86 - $23.44 $758 - $1,054	45 Added 45.92%	143 $3,000
Q1 2020 May 07, 2020	SELL	$14.47 - $27.96 $4,702 - $9,087	-325 Reduced 76.83%	98 $1.75 Million
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $7,152 - $15,342	423 New	423 $7.7 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.